9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
AssigneeBoehringer Ingelheim International GmbH
InventorsWaldemar PFRENGLE, Guenther HUCHLER, Markus OSTERMEIER, Peter SIEGER
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula (I), which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation and their use for the treatment of diseases, particularly tumoral diseases, benign prostatic hyperplasia and diseases of the lungs and airways.
Claims4
1-2. (canceled)
A method for the treatment of inflammatory or allergic diseases of the airways comprising administering a therapeutically effective amount of the compound of formula (I), characterized in that reflections in the X-ray powder diagram occur at dhkl values of 7.11, 5.77, 4.69, 4.36, 4.15, 3.85 and 3.61 Å, optionally in the form of a tautomer thereof, to a patient in need thereof
4-18. (canceled)
Dependencies are inferred from the claim text.